CTKB
Cytek BioSciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.01
+0.01 ▲ +0.25%
🌙 3월 13일 5:33 PM ET (한국 3/14 06:33)
$4.05
+0.04 ▲ +0.90%
| Index | RUT | P/E | - | EPS (ttm) | -0.52 | Insider Own | 9.32% | Shs Outstand | 0.13B | Perf Week | -4.98% |
| Market Cap | 0.52B | Forward P/E | - | EPS next Y | 31.43% | Insider Trans | - | Shs Float | 0.12B | Perf Month | -8.03% |
| Enterprise Value | 0.29B | PEG | - | EPS next Q | -0.1 | Inst Own | 64% | Short Float | 6.25% | Perf Quarter | -18.83% |
| Income | -0.07B | P/S | 2.56 | EPS this Y | 59.62% | Inst Trans | 1.31% | Short Ratio | 8.04 | Perf Half Y | -2.91% |
| Sales | 0.20B | P/B | 1.51 | EPS next 5Y | 55.23% | ROA | -13.81% | Short Interest | 7.28M | Perf YTD | -20.59% |
| Book/sh | 2.66 | P/C | 1.97 | EPS past 3/5Y | - | ROE | -18.05% | 52W High | -35.11% ($6.18) | Perf Year | -3.14% |
| Cash/sh | 2.03 | P/FCF | - | Sales past 3/5Y | 7.1% 16.76% | ROIC | -18.33% | 52W Low | 69.2% ($2.37) | Perf 3Y | -57.52% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -1062.64% | Gross Margin | 51.84% | Volatility(W/M) | 4.72% 5.22% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.42 | Sales Y/Y TTM | 0.52% | Oper. Margin | -20.04% | ATR (14) | 0.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.42 | EPS Q/Q | -560.99% | Profit Margin | -33.02% | RSI (14) | 31.49 | Recom | 2.2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.04 | Sales Q/Q | 8.12% | SMA20 | -6.8% ($4.3) | Beta | 1.33 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 2000000 | SMA50 | -16.39% ($4.8) | Rel Volume | 0.89 | Prev Close | $4 |
| Employees | 700 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | -1600% 8.73% | SMA200 | -5.16% ($4.23) | Avg Volume(3M) | 0.91M | Price | $4.01 |
| IPO | 2021/7/23 | Option/Short | Yes/Yes | Trades | 6109 | Volume | 804,677 | Change | 0.25% |
뉴스 로딩 중...